secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001493152-25-027744
Event type: leadership
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Jeffrey Fink resigns from Lipocine Board effective Jan 1, 2026
-----------------------------------------------------------------------

- Jeffrey Fink informed the Board on Dec 12, 2025 of his resignation effective Jan 1, 2026 for personal reasons.
- Resignation not due to any disagreement with the Company on any matter.
- Board intends to conduct a search for a new director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000149315225027744/0001493152-25-027744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000149315225027744/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer